It has been wonderful to hear your enthusiastic feedback about The Happy Lungs Project’s recent updates about our path forward. That, coupled with the loss of a dear friend, strengthens my own resolve and underscores the importance of our work.
As we continue to deliver on our new mission statement – to save the lives of RET-positive lung cancer patients by advancing research and treatment options – here’s what I’m especially excited to highlight:
We’re collaborating with 23andMe and 20+ patient advocacy organizations on the Lung Cancer Genetics Study, a new study to help advance research in lung cancer
Scientific research can be confusing and overwhelming, and that’s why The Happy Lungs Project is here:
We remain very grateful for your support, and we look forward to continuing to connect with you.
With love and light (in honor of my friend Shenell),
Ilana Stromberg
P.S. If you didn’t see my video message last month, I’ve included it again below.
Happy Lungs Headlines
Mapping the Route: Exploring the Spread of Non-Small Cell Lung Cancer
Understanding how and why RET-positive non-small cell lung cancer (NSCLC) spreads could be the key to transforming how to treat lung cancer and improving outcomes. Read the blog post
Why Lung Cancer Biomarker Testing Matters for RET-Positive Patients
Lung cancer biomarker testing is a crucial tool for RET-positive lung cancer patients and can significantly impact treatment and prognosis. Read the blog post